Technologies for manufacturing biological drugs at scale, including continuous manufacturing, single-use bioreactors, and process analytical technology (PAT). Critical for making advanced therapies commercially viable.
Ginkgo Bioworks Signs Three New Pharma Partnerships for Cell Line Engineering
The synthetic biology platform expands its pharmaceutical footprint, applying its cell programming platform to optimize CHO cell lines for biologics manufacturing and engineer microbial strains for complex natural product synthesis.